Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03588806 · ClinicalTrials.gov registry record · Phase 4
Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills
A Phase 4 study, sponsored by Ajay Wasan, MD, Msc.
- Terminated
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT03588806 is a Phase 4 study that was terminated before completion, run by Ajay Wasan, MD, Msc. The registered enrollment target is 11 participants.
The verdict
NCT03588806, a Phase 4 study, was terminated before completion, sponsored by Ajay Wasan, MD, Msc.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study will examine how the use of Xtampza ER, an opioid analgesic packaged in openable microsphere-containing capsules, affects swallowing satisfaction, pain, and physical and mental health outcomes in chronic pain patients.
Interventions
- DRUG Xtampza ER (oxycodone)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2019-10-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03588806
The ClinicalTrials.gov registry entry for NCT03588806 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ajay Wasan, MD, Msc, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Xtampza ER (oxycodone) is the first listed.
NCT03588806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03588806 about?
NCT03588806 is a clinical study titled "Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills". This study will examine how the use of Xtampza ER, an opioid analgesic packaged in openable microsphere-containing capsules, affects swallowing satisfaction, pain, and physical and mental health outcomes in chronic pain patients.
What is the current status of trial NCT03588806?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2018-05-01. Estimated completion is 2019-10-31.
What interventions are being tested in trial NCT03588806?
The interventions under investigation include: Xtampza ER (oxycodone) (DRUG).
Who is sponsoring clinical trial NCT03588806?
This trial is sponsored by Ajay Wasan, MD, Msc, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.